Renal Hybrid-Closed Loop Study
Professor David O'Neal
Glycemic control in patients living with both advanced renal disease and diabetes has traditionally proven to be difficult for both the patient and their care providers. With the rapid development of technologies to aid those living with diabetes, there is a great potential to utilize these technologies to benefit this cohort.
In order to remedy this, we are conducting a world first multi-site trial utilizing next generation hybrid closed loop insulin pump therapy(artificial pancreas) with the Medtronic MiniMed 780G in patients with type 1 and type 2 diabetes with advanced renal disease including those on haemo- and peritoneal dialysis. This is then compared and contrasted against the usual care these patients are provided with the goal of alleviating the mental, emotional and psychical burdens of their treatment.
Professor David O'Neal, Project Lead
Catriona Sims, Project Portfolio Manager
Dr. Jean Lu, Endocrinologist/PHD Student
Sally Double, Credentialed Diabetes Educator
Professor Steve Stranks
Professor Chris Nolan
Associate Professor Elif Ekinci
Associate Professor Spiros Fourlanos
The Australian Centre for Accelerating Diabetes Innovations Research Centre (ACADI) was established through MRFF funding from the Australian Government’s Targeted Translation Research Accelerator (TTRA) program, delivered by MTPConnect.